Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer
Renaud Sabatier, Véronique Diéras, Xavier Pivot, Etienne Brain, Henri Roché, Jean-Marc Extra, Audrey Monneur, Magali Provansal, Carole Tarpin, François Bertucci, Patrice Viens, Christophe Zemmour, Anthony Gonçalves
Cancer Res Treat. 2018;50(4):1226-1237.   Published online 2017 Dec 28     DOI:
Citations to this article as recorded by Crossref logo
Breast cancer treatment-related cardiovascular disturbances: advocacy for a watchful attitude in this never-ending story
Charlène Rivier, Benoite Mery, Elise Rowinski, Sandrine Sotton, Wafa Bouleftour, Laurent Bertoletti, Olivier Tredan, Nicolas Magne
Expert Opinion on Drug Safety.2022; 21(4): 453.     CrossRef
Optimization of G-CSF dosing schedule in patients treated with eribulin: a modeling approach
Manon Reda, Pauline Macaire, Hélène Bellio, Lionel Uwer, Silvia Ilie, Véronique Lorgis, Audrey Hennequin, Sylvain Ladoire, Emilie Rederstorff, Pierre Fumoleau, Nicolas Isambert, Nathalie Bonnin, Benoit You, Gilles Freyer, Isabelle Desmoulins, Antonin Schm
Cancer Chemotherapy and Pharmacology.2022; 89(2): 197.     CrossRef
Eribulin Efficacy on Brain Metastases in Heavily Pretreated Patients with Metastatic Breast Cancer
Renaud Sabatier, Johan Martin, Cécile Vicier, Mathilde Guérin, Audrey Monneur, Magali Provansal, Louis Tassy, Carole Tarpin, Jean-Marc Extra, Frédéric Viret, Anthony Goncalves
Journal of Clinical Medicine.2021; 10(6): 1272.     CrossRef
The relative effectiveness of eribulin for advanced breast cancer treatment: a study of the southeast Netherlands advanced breast cancer registry
X. G. L. V. Pouwels, S. M. E. Geurts, B. L. T. Ramaekers, F. Erdkamp, B. E. P. J. Vriens, K. N. A. Aaldering, A. J. van de Wouw, M. W. Dercksen, T. J. Smilde, N. A. J. B. Peters, J. M. van Riel, M. J. Pepels, J. Heijnen-Mommers, M. A. Joore, V. C. G. Tjan
Acta Oncologica.2020; 59(1): 82.     CrossRef
Systematic review of Real-World effectiveness of eribulin for locally advanced or metastatic breast cancer
Isabelle Chabot, Qi Zhao, Yun Su
Current Medical Research and Opinion.2020; 36(12): 2025.     CrossRef
Real‐life activity of eribulin mesylate among metastatic breast cancer patients in the multicenter national observational ESME program
William Jacot, Pierre‐Etienne Heudel, Julien Fraisse, Sophie Gourgou, Séverine Guiu, Florence Dalenc, Barbara Pistilli, Mario Campone, Christelle Levy, Marc Debled, Marianne Leheurteur, Marie Chaix, Claudia Lefeuvre, Anthony Goncalves, Lionel Uwer, Jean‐M
International Journal of Cancer.2019; 145(12): 3359.     CrossRef